Mark Galperin

  • Beltsville, MD
  • Pain medicine (anesthesiology) physician
NPI1760424543PAC ID3870571805
Medicare services, 2024
2,855
Medicare patients, 2024
266
Part D claims, 2024
626
Publications
1
MIPS score, 2024
37
Practice address
8000 Virginia Manor Rd, Beltsville, MD 20705
Practice phone
Call (862) 803-1079
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Theranostix Inc

Beltsville, Maryland

See all 3 affiliations

Find Mark Galperin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Mark Galperin is a pain medicine (anesthesiology) physician in Beltsville, Maryland

Mark Galperin practices at Theranostix Inc in Beltsville, Maryland.

Mark Galperin's NPI, 1760424543, was assigned on June 13, 2006. Mark Galperin holds New York license 211587.

NPI and contact details
Medicare PAC ID
3870571805
NPI enumeration date
June 13, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(862) 803-1079
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Mark Galperin practices at Theranostix Inc in Beltsville, Maryland

Mark Galperin's primary practice is Theranostix Inc, at 8000 Virginia Manor Rd, Beltsville, MD 20705 in Prince Georges County. The practice phone is (862) 803-1079.

  • Theranostix Inc
    8000 Virginia Manor Rd, Beltsville, MD 20705 · Prince Georges CountyPhone(862) 803-1079

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Mark Galperin is affiliated with 2 sites of care and 1 medical group

Mark Galperin's primary practice is Theranostix Inc in Beltsville, Maryland. The medical group on file is Mark Galperin, MD. Dmand AI also links Mark Galperin to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Mark Galperin

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Mark Galperin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Galperin practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Theranostix IncAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Mark Galperin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Mark Galperin is one of 95 pain medicine (anesthesiology) physicians in Maryland

Pain medicine is Mark Galperin's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Mark Galperin is licensed in New York.

Specialties and state licenses

  • Pain medicine (anesthesiology), New YorkPrimaryLicense 211587 · taxonomy 207LP2900X

Pain medicine (anesthesiology) physicians near Mark Galperin

Counts of pain medicine (anesthesiology) physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Mark Galperin billed Medicare for 2,855 services in 2024

CMS data shows 2,855 Medicare services from Mark Galperin across 19 procedure codes in 2024, for 266 Medicare patients. Medicare paid $145,662 for them. Every service was in an office.

Medicare services, 20242,855
Medicare patients266
Paid by Medicare$145,662
Procedure codes19

Mark Galperin's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 1,4882024: 1,6148%
Office and hospital visits
2023: 5552024: 5403%
Surgery
2023: 5612024: 5335%
Anesthesia
2023: 842024: 7610%
Imaging
2023: 502024: 492%
Lab and pathology
2023: 902024: 4352%

Mark Galperin compared with the Maryland median for pain medicine (anesthesiology) physicians, 2024

  • Mark Galperin
  • Maryland median
Medicare services
2,855vs 1,0062.8 times
Medicare patients
266vs 29811% below
Part D claims
563vs 5945% below

Medians across 100 pain medicine (anesthesiology) physicians in Maryland with Dmand AI profiles that report each measure.

Mark Galperin's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Mark Galperin

Need commercial claims for Mark Galperin?

Medicare shows one payer. Book a meeting to get commercial claims data for Mark Galperin and other pain medicine (anesthesiology) physicians in Maryland.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Mark Galperin treated 266 Medicare patients in 2024, average age 78

CMS counts 266 Medicare patients who saw Mark Galperin in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have arthritis, and 75% have high blood pressure. 85% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Galperin's median patient age at 65, with 50% women.

Medicare patients, 2024266
Average age78
Average risk score1.87
Also on Medicaid85%

Mark Galperin's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Mark Galperin's Medicare patients by sex, 2024

  • Women17566%
  • Men9134%

Chronic conditions among Mark Galperin's Medicare patients, 2024

  1. Arthritis75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes72%
  5. Ischemic heart disease63%
  6. Mood disorders48%
  7. Depression45%
  8. Heart failure40%

Share of Medicare patients with each condition. A patient can have several.

Mark Galperin's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women50%
  • Men45%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Mark Galperin wrote 626 Medicare Part D claims in 2024

In 2024, Mark Galperin wrote 626 Medicare Part D claims for 138 patients. 90% of them were for generic drugs. CMS names the drug for 563 of them, across 15 drugs with 11 or more claims each, at $67,799 in total drug cost. In 2023, CMS named 406 claims across 10 drugs.

Part D claims, 2024626
Drugs named by CMS15
Total drug cost$67,799
Part D patients138

Mark Galperin's Part D claims by kind of drug, 2024

  • Generic565 claims90%
  • Brand-name61 claims10%

Mark Galperin's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Mark Galperin's Part D claims, 2024

  • Opioids43%271 of 626 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4062024: 56339%

Drugs named by CMS: 15 in 2024, 10 in 2023.

See all prescribing by Mark Galperin

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Mark Galperin scored 37 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 37 out of 100 for Mark Galperin for performance year 2024, reported individually. Mark Galperin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Mark Galperin's MIPS scores, performance year 2024

  • 37of 100Final score
  • 15of 100Quality
  • 0of 100Improvement Activities
  • 70of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find pain medicine (anesthesiology) physicians like Mark Galperin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Mark Galperin has 1 publication on record

Dmand AI links 1 paper to Mark Galperin. Mark Galperin's most frequent co-author is Eliezer Soto, MD.

Papers1

Mark Galperin's most frequent co-authors

Recent publications by Mark Galperin

See all 1 publications and co-authors

See who Mark Galperin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Mark Galperin works with, so you can find a warm path to the right pain medicine (anesthesiology) physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Mark Galperin received $8,899 in industry payments from 2016 to 2025

CMS Open Payments shows 170 general payments to Mark Galperin from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Abbott Laboratories paid the most, $3,231.

General payments to Mark Galperin by program year, 2016 to 2025

General payments to Mark Galperin by kind, 2016 to 2025

$8.9Kin total
  • Food and beverage$4,94456%
  • Speaker and faculty fees$3,23136%
  • Travel and lodging$6317%
  • Consulting fees$901%
  • Education$30%

Companies that paid Mark Galperin the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Mark Galperin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Mark Galperin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Mark Galperin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Mark Galperin's NPI number?

Mark Galperin's NPI number is 1760424543. It was assigned on June 13, 2006, and it is active in the NPI Registry.

What does Mark Galperin specialize in?

Mark Galperin is a pain medicine (anesthesiology) physician in Beltsville, Maryland. The primary specialty in the NPI Registry is Pain Medicine (Anesthesiology) Physician (taxonomy code 207LP2900X).

Where does Mark Galperin practice?

Mark Galperin practices at 8000 Virginia Manor Rd, Beltsville, MD 20705. Mark Galperin's primary practice is Theranostix Inc in Beltsville, Maryland. Dmand AI also links Mark Galperin to 1 group practice or clinic.

What is Mark Galperin's office phone number?

The practice phone on file for Mark Galperin is (862) 803-1079.

What is Mark Galperin's medical license number?

Mark Galperin holds New York license 211587.

What medical group is Mark Galperin part of?

Mark Galperin is linked to Mark Galperin, MD.

Does Mark Galperin accept Medicare?

Yes. CMS data shows Mark Galperin billed Medicare for 2,855 services in 2024, and Mark Galperin accepts Medicare assignment.

What is Mark Galperin's MIPS score?

Mark Galperin's MIPS final score for performance year 2024 is 37 out of 100, reported individually.

How many Medicare patients does Mark Galperin see?

CMS counts 266 Medicare patients who saw Mark Galperin in 2024, with an average age of 78.

What services does Mark Galperin bill to Medicare?

In 2024, Mark Galperin's most billed Medicare services were injected or infused drug (J3301), office visit, established patient (99213) and office visit, new patient (99204).

Show 5 more questionsShow fewer questions

What drugs does Mark Galperin prescribe most?

In 2024 Medicare Part D data, Mark Galperin's most prescribed drugs by claims were Gabapentin, Oxycodone HCl and Methadone HCl.

Has Mark Galperin received payments from drug or device companies?

CMS Open Payments shows $8,899 in general payments to Mark Galperin from 27 companies from 2016 to 2025. The largest total came from Abbott Laboratories.

How long has Mark Galperin been practicing?

Mark Galperin graduated from medical school in 1989, 37 years ago.

Does Mark Galperin do research?

Dmand AI links 1 publication to Mark Galperin.

Who does Mark Galperin publish with?

Mark Galperin's most frequent co-authors are Eliezer Soto, MD (1 shared paper).

Selling to pain medicine practices?

See pain medicine (anesthesiology) physicians in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)